• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

运动员使用处方药的情况。

Use of prescription drugs in athletes.

作者信息

Alaranta Antti, Alaranta Hannu, Helenius Ilkka

机构信息

Nutrimed Ltd, Helsinki, Finland.

出版信息

Sports Med. 2008;38(6):449-63. doi: 10.2165/00007256-200838060-00002.

DOI:10.2165/00007256-200838060-00002
PMID:18489193
Abstract

Although athletes are young and generally healthy, they use a variety of non-doping classified medicines to treat injuries, cure illnesses and obtain a competitive edge. Athletes and sports medicine physicians try to optimize the treatment of symptoms related to extreme training during an elite athlete's active career. According to several studies, the use of antiasthmatic medication is more frequent among elite athletes than in the general population. The type of training and the kind of sport influence the prevalence of asthma. Asthma is most common among those competing in endurance events, such as cycling, swimming, cross-country skiing and long-distance running. Recent studies show that athletes use also NSAIDs and oral antibacterials more commonly than age-matched controls, especially athletes competing in speed and power sports. Inappropriately high doses and concomitant use of several different NSAIDs has been observed. All medicines have adverse effects that may have deleterious effects on elite athletes' performance. Thus, any unnecessary medication use should be minimized in elite athletes. Inhaled beta(2)-agonists may cause tachycardia and muscle tremor, which are especially harmful in events requiring accuracy and a steady hand. In experimental animal models of acute injury, especially selective cyclo-oxygenase-2 inhibitors have been shown to be detrimental to tissue-level repair. They have been shown to impair mechanical strength return following acute injury to bone, ligament and tendon. This may have clinical implications for future injury susceptibility. However, it should be noted that the current animal studies have limited translation to the clinical setting. Adverse effects related to the CNS and gastrointestinal adverse reactions are commonly reported in connection with NSAID use also in elite athletes. In addition to the potential for adverse effects, recent studies have shown that NSAID use may negatively regulate muscle growth by inhibiting protein synthesis. Physicians and pharmacists taking care of athletes' medication need to be aware of the medicines that an athlete is taking and how those medicines interact with performance, exercise, environment and other medicines. Sport associations should repeatedly monitor not only the use of banned substances, but also the trends of use of legal medicines in athletes. Not only physicians and pharmacists, but also athletes and coaches should be better educated with respect to potential benefits and risks, and how each agent may affect an athlete's performance. The attitudes and beliefs leading to ample use of legal medicines in athletes is an interesting area of future research.

摘要

尽管运动员年轻且总体健康,但他们会使用各种未被列为兴奋剂的药物来治疗伤痛、治愈疾病并获取竞争优势。运动员和运动医学医生试图在精英运动员的活跃职业生涯中优化与极限训练相关症状的治疗。根据多项研究,精英运动员中使用抗哮喘药物的频率高于普通人群。训练类型和运动项目会影响哮喘的患病率。哮喘在参加耐力项目的运动员中最为常见,如自行车、游泳、越野滑雪和长跑。最近的研究表明,与年龄匹配的对照组相比,运动员使用非甾体抗炎药(NSAIDs)和口服抗菌药物的情况也更为普遍,尤其是参加速度和力量型运动的运动员。已观察到存在不适当的高剂量使用以及同时使用几种不同NSAIDs的情况。所有药物都有不良反应,可能会对精英运动员的表现产生有害影响。因此,应尽量减少精英运动员不必要的药物使用。吸入型β₂激动剂可能会导致心动过速和肌肉震颤,这在需要精准度和稳定手部的项目中尤其有害。在急性损伤的实验动物模型中,特别是选择性环氧化酶-2抑制剂已被证明对组织水平的修复有害。它们已被证明会损害骨骼、韧带和肌腱急性损伤后机械强度的恢复。这可能对未来的受伤易感性有临床意义。然而,应注意的是,目前的动物研究在临床应用中的转化有限。与NSAIDs使用相关的中枢神经系统不良反应和胃肠道不良反应在精英运动员中也经常被报告。除了潜在的不良反应外,最近的研究表明,NSAIDs的使用可能通过抑制蛋白质合成对肌肉生长产生负面调节作用。负责运动员用药的医生和药剂师需要了解运动员正在服用的药物以及这些药物如何与表现、运动、环境和其他药物相互作用。体育协会不仅应反复监测违禁物质的使用情况,还应监测运动员使用合法药物的趋势。不仅医生和药剂师,运动员和教练也应更好地了解潜在的益处和风险,以及每种药物可能如何影响运动员的表现。导致运动员大量使用合法药物的态度和观念是未来研究的一个有趣领域。

相似文献

1
Use of prescription drugs in athletes.运动员使用处方药的情况。
Sports Med. 2008;38(6):449-63. doi: 10.2165/00007256-200838060-00002.
2
Ample use of physician-prescribed medications in Finnish elite athletes.芬兰精英运动员大量使用医生开的药物。
Int J Sports Med. 2006 Nov;27(11):919-25. doi: 10.1055/s-2006-923811. Epub 2006 Feb 14.
3
Do inhaled beta(2)-agonists have an ergogenic potential in non-asthmatic competitive athletes?吸入性β2受体激动剂对非哮喘性竞技运动员是否具有增强运动能力的潜力?
Sports Med. 2007;37(2):95-102. doi: 10.2165/00007256-200737020-00001.
4
Doping in sport: a review of elite athletes' attitudes, beliefs, and knowledge.运动中的兴奋剂:对精英运动员的态度、信念和知识的回顾。
Sports Med. 2013 Jun;43(6):395-411. doi: 10.1007/s40279-013-0037-x.
5
Self-reported attitudes of elite athletes towards doping: differences between type of sport.精英运动员对使用兴奋剂的自我报告态度:不同运动项目之间的差异。
Int J Sports Med. 2006 Oct;27(10):842-6. doi: 10.1055/s-2005-872969. Epub 2006 Feb 1.
6
Asthma medication in Finnish olympic athletes: no signs of inhaled beta2-agonist overuse.芬兰奥运运动员的哮喘药物使用情况:无吸入性β2激动剂过度使用迹象。
Med Sci Sports Exerc. 2004 Jun;36(6):919-24. doi: 10.1249/01.mss.0000128250.17793.47.
7
Allergy and asthma in elite summer sport athletes.精英夏季运动运动员的过敏与哮喘
J Allergy Clin Immunol. 2000 Sep;106(3):444-52. doi: 10.1067/mai.2000.107749.
8
Asthma in elite athletes.精英运动员中的哮喘。
Expert Rev Respir Med. 2011 Jun;5(3):343-51. doi: 10.1586/ers.11.28.
9
An (un)desirable trade of harms? How elite athletes might react to medically supervised 'doping' and their considerations of side-effects in this situation.一种(非)理想的伤害交换?精英运动员在这种情况下对医学监督的“兴奋剂”可能会做出何种反应,以及他们对副作用的考虑。
Int J Drug Policy. 2018 May;55:14-30. doi: 10.1016/j.drugpo.2017.12.019. Epub 2018 Feb 22.
10
Asthma in elite athletes: how do we manage asthma-like symptoms and asthma in elite athletes?精英运动员中的哮喘:我们如何管理精英运动员的哮喘样症状和哮喘?
Clin Respir J. 2009 Apr;3(2):123. doi: 10.1111/j.1752-699X.2008.00111.x.

引用本文的文献

1
Usage of analgesic and anti-inflammatory medicine by Egyptian male international footballers: what are the patterns and the perceptions towards sports pharmacy and medication use?埃及男性国际足球运动员使用止痛和抗炎药物的情况:对运动药房和药物使用的模式及看法是怎样的?
BMJ Open Sport Exerc Med. 2025 Jul 28;11(3):e002605. doi: 10.1136/bmjsem-2025-002605. eCollection 2025.
2
A single, maximal dose of celecoxib, ibuprofen, or flurbiprofen does not reduce the muscle signalling response to plyometric exercise in young healthy adults.单剂量最大量的塞来昔布、布洛芬或氟比洛芬不会降低年轻健康成年人对增强式运动的肌肉信号反应。
Eur J Appl Physiol. 2024 Dec;124(12):3607-3617. doi: 10.1007/s00421-024-05565-5. Epub 2024 Jul 24.
3

本文引用的文献

1
Exercise-induced asthma.运动诱发性哮喘
Phys Sportsmed. 1999 Nov;27(12):75-92. doi: 10.3810/psm.1999.11.1106.
2
Ephedrine, pseudoephedrine, and amphetamine prevalence in college hockey players: most report performance-enhancing use.大学生曲棍球运动员中麻黄碱、伪麻黄碱和苯丙胺的流行情况:大多数人报告使用这些物质来提高成绩。
Phys Sportsmed. 2004 Sep;32(9):30-4. doi: 10.3810/psm.2004.09.551.
3
The influence of anti-inflammatory medication on exercise-induced myogenic precursor cell responses in humans.抗炎药物对人体运动诱导的肌源性前体细胞反应的影响。
The Essential and Optimal Analgesic and Anti-Inflammatory Medicines for Athletes at the Olympic Games.
奥运会运动员的基本和最佳镇痛与抗炎药物
Sports Med Open. 2024 Jul 19;10(1):80. doi: 10.1186/s40798-024-00743-3.
4
A survey and knowledge assessment of Albertan pharmacists providing pharmacy services to athlete-patients.一项针对为运动员患者提供药学服务的艾伯塔省药剂师的调查与知识评估。
Can Pharm J (Ott). 2023 Jul 26;156(5):243-246. doi: 10.1177/17151635231188347. eCollection 2023 Sep-Oct.
5
Prevalence and Pattern of Injuries Across the Weight-Training Sports.力量训练运动中损伤的患病率及模式
Cureus. 2023 Nov 30;15(11):e49759. doi: 10.7759/cureus.49759. eCollection 2023 Nov.
6
Use of pharmaceuticals amongst athletes tested by Anti-Doping Norway in a five-year period.挪威反兴奋剂机构在五年时间里对运动员进行药物检测的情况。
Front Sports Act Living. 2023 Oct 4;5:1260806. doi: 10.3389/fspor.2023.1260806. eCollection 2023.
7
A Validation Study of a Deep Learning-Based Doping Drug Text Recognition System to Ensure Safe Drug Use among Athletes.基于深度学习的兴奋剂药物文本识别系统的验证研究,以确保运动员安全用药。
Healthcare (Basel). 2023 Jun 15;11(12):1769. doi: 10.3390/healthcare11121769.
8
Feasibility of mixed herbal medicine for improving gastric function in an alcohol-induced gastritis model.混合草药改善酒精性胃炎模型胃功能的可行性
Phys Act Nutr. 2023 Mar;27(1):1-8. doi: 10.20463/pan.2023.0001. Epub 2023 Mar 31.
9
Analgesic Use in Sports.运动中的镇痛剂使用。
Dtsch Arztebl Int. 2023 Mar 10;120(10):155-161. doi: 10.3238/arztebl.m2023.0003.
10
Pharmacological Treatment for Acute Traumatic Musculoskeletal Pain in Athletes.运动员急性创伤性肌肉骨骼疼痛的药物治疗。
Medicina (Kaunas). 2021 Nov 5;57(11):1208. doi: 10.3390/medicina57111208.
J Appl Physiol (1985). 2007 Aug;103(2):425-31. doi: 10.1152/japplphysiol.00157.2007. Epub 2007 Apr 26.
4
Do inhaled beta(2)-agonists have an ergogenic potential in non-asthmatic competitive athletes?吸入性β2受体激动剂对非哮喘性竞技运动员是否具有增强运动能力的潜力?
Sports Med. 2007;37(2):95-102. doi: 10.2165/00007256-200737020-00001.
5
Topical ketoprofen TDS patch versus diclofenac gel: efficacy and tolerability in benign sport related soft-tissue injuries.外用酮洛芬透皮给药系统贴片与双氯芬酸凝胶的比较:对与运动相关的良性软组织损伤的疗效和耐受性
Br J Sports Med. 2007 Mar;41(3):134-9. doi: 10.1136/bjsm.2006.030239. Epub 2006 Nov 30.
6
Randomized controlled noninferiority trial to compare extended release acetaminophen and ibuprofen for the treatment of ankle sprains.比较缓释对乙酰氨基酚和布洛芬治疗踝关节扭伤的随机对照非劣效性试验。
Ann Emerg Med. 2006 Nov;48(5):615-23. doi: 10.1016/j.annemergmed.2006.05.015. Epub 2006 Sep 1.
7
Patterns of allergic reactivity and disease in Olympic athletes.奥运会运动员的过敏反应和疾病模式。
Clin J Sport Med. 2006 Sep;16(5):401-5. doi: 10.1097/01.jsm.0000244606.56935.59.
8
Using recovery modalities between training sessions in elite athletes: does it help?精英运动员在训练间隙使用恢复方式:这有帮助吗?
Sports Med. 2006;36(9):781-96. doi: 10.2165/00007256-200636090-00005.
9
Ibuprofen inhibits skeletal muscle hypertrophy in rats.布洛芬抑制大鼠骨骼肌肥大。
Med Sci Sports Exerc. 2006 May;38(5):840-6. doi: 10.1249/01.mss.0000218142.98704.66.
10
Practical management: nonsteroidal antiinflammatory drug (NSAID) use in athletic injuries.实用管理:非甾体抗炎药(NSAID)在运动损伤中的应用
Clin J Sport Med. 2006 Mar;16(2):170-4. doi: 10.1097/00042752-200603000-00015.